However, the authors observed a potential improvement in serum BDNF levels and both treatment regimens appeared to improve baseline scores of the Center for Epidemiological Studies Depression Scale (CES-D), a screening instrument for depression [57]. The gene discussed is BDNF; the disease is depressive symptom measurement.